• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
CTRI - Clicking to greater transparency and accountability.CTRI - 点击实现更高的透明度和问责制。
Perspect Clin Res. 2012 Oct;3(4):122-4. doi: 10.4103/2229-3485.103592.
2
Public disclosure of clinical trial results at Clinical Trial Registry of India- Need for transparency in research!印度临床试验注册中心对临床试验结果的公开披露——研究需要透明度!
Perspect Clin Res. 2023 Apr-Jun;14(2):81-85. doi: 10.4103/picr.picr_39_22. Epub 2022 Nov 14.
3
Clinical Trials Registry - India: A decadal perspective.临床试验注册印度:十年展望。
Indian J Pharmacol. 2020 Jul-Aug;52(4):272-282. doi: 10.4103/ijp.IJP_24_20.
4
Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020.对2009年至2020年在印度临床试验注册中心注册的阿育吠陀研究的分析。
J Ayurveda Integr Med. 2021 Apr-Jun;12(2):346-350. doi: 10.1016/j.jaim.2021.04.004. Epub 2021 May 20.
5
Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match.来自印度药品监管机构以及“印度临床试验注册中心”的数据并非总是一致。
Front Med (Lausanne). 2024 Feb 15;11:1346208. doi: 10.3389/fmed.2024.1346208. eCollection 2024.
6
Publication of neurology clinical trials registered with clinical trial registry of India: A cross-sectional study.印度临床试验注册中心注册的神经病学临床试验发表情况:一项横断面研究。
Acta Neurol Scand. 2022 Nov;146(5):475-484. doi: 10.1111/ane.13669. Epub 2022 Jul 15.
7
An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India.对临床试验注册中心 - 印度登记的介入性药物试验数据缺陷的分析。
Trials. 2019 Aug 28;20(1):535. doi: 10.1186/s13063-019-3592-0.
8
Clinical Trials Registry - India: An overview and new developments.印度临床试验注册:概述与新进展
Indian J Pharmacol. 2018 Jul-Aug;50(4):208-211. doi: 10.4103/ijp.IJP_153_18.
9
Overview of trials registered with Clinical Trial Registry-India: Need for customized data set items.在印度临床试验注册中心注册的试验概述:对定制数据集项目的需求。
Ayu. 2020 Jul-Sep;41(3):143-147. doi: 10.4103/ayu.ayu_375_21. Epub 2022 Feb 24.
10
Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law.潜在重复:数以百计的印度临床试验已在 ClinicalTrials.gov 注册,但根据法律要求,这些试验并未在印度注册。
PLoS One. 2020 Jun 19;15(6):e0234925. doi: 10.1371/journal.pone.0234925. eCollection 2020.

引用本文的文献

1
An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India.对临床试验注册中心 - 印度登记的介入性药物试验数据缺陷的分析。
Trials. 2019 Aug 28;20(1):535. doi: 10.1186/s13063-019-3592-0.
2
A Case-Study of the Resources and Functioning of Two Research Ethics Committees in Western India.印度西部两个研究伦理委员会的资源与运作案例研究。
J Empir Res Hum Res Ethics. 2016 Dec;11(5):387-396. doi: 10.1177/1556264616636235. Epub 2016 Jul 31.

本文引用的文献

1
Registration of clinical trials: An idea whose time has come!
Indian J Pharmacol. 2008 Mar;40(2):47-8. doi: 10.4103/0253-7613.41037.
2
Clinical Trials Registry--India: redefining the conduct of clinical trials.印度临床试验注册中心:重新定义临床试验的实施
Indian J Cancer. 2008 Jul-Sep;45(3):79-82. doi: 10.4103/0019-509x.44060.
3
Registering clinical trials in India: a scientific and ethical imperative.在印度注册临床试验:一项科学和伦理的必要举措。
Natl Med J India. 2008 Jan-Feb;21(1):31-4.
4
Clinical trial registration--looking back and moving ahead.临床试验注册——回顾与展望
N Engl J Med. 2007 Jun 28;356(26):2734-6. doi: 10.1056/NEJMe078110. Epub 2007 Jun 4.
5
Registering a clinical trial in ClinicalTrials.gov.在ClinicalTrials.gov上注册一项临床试验。
Chest. 2007 Mar;131(3):909-912. doi: 10.1378/chest.06-2450. Epub 2007 Feb 15.
6
Clinical trial registration: a statement from the International Committee of Medical Journal Editors.临床试验注册:国际医学期刊编辑委员会声明
N Engl J Med. 2004 Sep 16;351(12):1250-1. doi: 10.1056/NEJMe048225. Epub 2004 Sep 8.

CTRI - 点击实现更高的透明度和问责制。

CTRI - Clicking to greater transparency and accountability.

作者信息

George Bobby

机构信息

AVP and Head Regulatory Affairs, Reliance Life Sciences Pvt. Ltd., Dhirubhai Ambani Life Sciences Centre, Rabale, Navi Mumbai, India.

出版信息

Perspect Clin Res. 2012 Oct;3(4):122-4. doi: 10.4103/2229-3485.103592.

DOI:10.4103/2229-3485.103592
PMID:23293758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3530978/
Abstract

A clinical trial registry (CTR) is an official platform for registering a clinical trial (CT) with an objective of providing increased transparency and access to CTs to the public at large. Clinical Trials Registry - India (CTRI) is a free online public record system for registration of CTs being conducted in India. The vision of the CTRI is to ensure that every CT conducted in the region is prospectively registered with full disclosure of the trial data set items. With more number of CTs being conducted in the country, with a large number being global multicentre trials, it is binding on the industry/investigators/sponsor to comply with the requirements laid down. While there are pros and cons, there is enough scope for improvement of CTRI.

摘要

临床试验注册库(CTR)是一个用于注册临床试验(CT)的官方平台,其目的是提高透明度,让广大公众能够获取临床试验信息。印度临床试验注册库(CTRI)是一个免费的在线公共记录系统,用于注册在印度开展的临床试验。CTRI的愿景是确保该地区开展的每项临床试验都能进行前瞻性注册,并全面披露试验数据集项目。随着该国开展的临床试验数量增多,其中大量是全球多中心试验,行业/研究者/申办者有义务遵守规定的要求。虽然有利有弊,但CTRI仍有很大的改进空间。